Rigel reiterated by JMP at market outperform

Rigel Pharmaceuticals Inc. was reiterated by JMP Securities analyst Adam Cutler at a market outperform rating with a price target on the stock of $25 per share following second-quarter results. Rigel shares were down $0.41, or 1.88%, to $21.38 on volume of 190,171 shares versus the three-month running average of 229,611 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.